Beacon Analyst Gabriel Leung Likes This Canadian Healthcare Stock

Beacon Securities analyst Gabriel Leung reiterated his “Speculative Buy” rating and $8.50 aim price on Hydreight Utilized sciences (Hydreight Utilized sciences Stock Quote, Chart, Info, Analysts, Financials TSXV:NURS) in an Oct. 23 substitute, citing sturdy order momentum and growing adoption all through the company’s U.S. digital healthcare neighborhood.

Beacon initiated safety of the stock on Oct. 20.

Las Vegas-based Hydreight is setting up a “compliance-first” mobile clinic neighborhood that connects licensed healthcare suppliers with victims by way of its VSDHOne direct-to-consumer platform.

Leung said the company processed roughly 295,000 VSDHOne product orders between July and September, pushed by demand for weight administration, hormone treatment, NAD, and genetic testing suppliers.

“With July orders at 35,600 and August at larger than 80,000, which will recommend September reached a report 179,000,” he said. “VSDHOne order traits are monitoring positively and are ahead of expectations—we had modeled 120,000 orders for September.”

Whereas Hydreight has however to disclose widespread order dimension or gross margins, Leung said administration expects momentum to proceed into the fourth quarter as additional licensees are onboarded. The company moreover reported 198 new nurse sign-ups in Q3, up 49% year-over-year, and 593 year-to-date, a 63% improve. Pharmacy orders outside of VSDHOne rose 72%, suggesting “sustained progress and broader adoption all through a variety of wellness verticals.”

Hydreight ended the quarter with $18.7-million in cash and $5.6-million in in-the-money warrants, positioning it for potential acquisitions in know-how, wellness, and digital nicely being. Leung added that the next catalyst should be the closing of Hydreight’s 5% equity funding in Wonderful Scripts LLC, which can “velocity up pharmacy orders by way of VSDHOne and add margin upside.”

Beacon forecasts Q3 revenue of $13.4-million and EBITDA of $754,000, representing 197% year-over-year revenue progress, with outcomes anticipated in mid- to late November. Leung estimates Hydreight will generate $2.5-million in Adjusted EBITDA on $43.4-million of revenue in 2025, bettering to $9.1-million on $100.8-million in 2026.

“Hydreight continues to ship robust working momentum, with key metrics monitoring successfully ahead of expectations,” Leung said.

-30-